How long after your Mounjaro injection does it start working?

The first 24–48 hours: absorption happens quietly

Picture this: you've done your first injection, you followed the technique, rotated the site, and the plain box it arrived in is already in the recycling. Nothing dramatic happens. That's expected.

Tirzepatide works by activating both GIP and GLP-1 receptors involved in appetite signalling and blood-sugar regulation. After a subcutaneous injection, the medicine is absorbed gradually from the fatty tissue under the skin. Peak plasma concentration is reached roughly 8–72 hours post-injection, though the mean is around 48 hours. You are unlikely to feel anything specific in this window. Some people notice very mild nausea toward the end of the first day; many notice nothing at all. The NHS tirzepatide medicines page confirms this gradual onset profile.

The practical upshot: don't judge the medicine by day one. If you're wondering how long after injecting Mounjaro it starts to work, absorption is already happening even when you can't feel it.

Weeks one to four: the first signs appetite is shifting

This is where most people start to notice something. Hunger between meals feels slightly less insistent. Portions that previously felt necessary start to feel like a bit much. The drive to finish everything on the plate softens a little.

These changes tend to be subtle at first, which surprises some patients who expected a sharp switch. The reason is pharmacokinetic: tirzepatide has a half-life of roughly five days, meaning steady-state blood levels accumulate across several weekly doses before the effect plateaus at a given dose. So the third injection at 2.5mg is doing more than the first, even at the same dose. For a clearer picture of how long after your first injection Mounjaro works, it helps to understand that earlier doses are building toward the steady-state levels that later doses achieve.

Side effects, if they appear, tend to arrive in this window too, mostly gastrointestinal: nausea, loose stools, a feeling of fullness after small amounts. They are generally mild and transient, often easing within the first two weeks. If you want a fuller picture of what to watch for and when, our guide to when Mounjaro side effects typically begin covers the timeline in detail.

Body weight at week four: don't expect dramatic numbers yet. The 2.5mg starting dose was not designed for maximum weight reduction. It exists so your GI system has time to adapt before the prescriber moves you up.

Weeks four to twelve: dose titration and when results become measurable

For many people, this is when Mounjaro starts to feel like it's doing something real. Once your prescriber has reviewed your response and moved you to 5mg, and then to 7.5mg, appetite suppression becomes more pronounced and caloric intake typically falls more substantially. Clinical trials in the SURMOUNT programme showed that meaningful weight loss accumulates progressively across weeks: those who saw the largest reductions at 72 weeks had started accumulating them by this stage. The SURMOUNT-1 trial, published in the New England Journal of Medicine, reported average body-weight reductions of around 20–21% at 15mg over 72 weeks.

The key variable is titration. People who tolerate dose increases well and move through the schedule as clinically directed tend to see faster, more consistent results. Those who stay on lower doses longer (whether due to side effects or clinical caution) will have a slower trajectory, which is entirely appropriate. Our page covering how long after injecting Mounjaro it works explains how this titration timeline affects when most people experience a noticeable response.

Cost context is worth knowing at this stage, because the dose you land on affects price. If that's on your mind, the context around Mounjaro UK pricing is worth reading, Eli Lilly revised UK list prices in September 2025, and private costs vary by dose and provider.

Tracking your weight weekly at the same time of day, ideally after your morning injection day, gives the clearest signal of whether the medicine is working for you at a given dose.

Beyond week twelve: what 'working' looks like long-term

Mounjaro is not a short course. Its licensed indication is ongoing weight management alongside a reduced-calorie diet and increased physical activity. The question shifts from "has it started working?" to "is it continuing to work at this dose?"

NICE guidance (TA1026) notes that if someone has not achieved at least 5% weight loss after six months at the highest tolerated dose, continuing treatment should be reviewed by the prescriber. That threshold gives a clear benchmark. If you are on track (and most people titrating properly are) you carry on.

Long-term responders in clinical trials continued losing weight well past week 12, with the plateau arriving somewhere between weeks 36 and 72 depending on dose and individual biology. The medicine is still "working" at that point, even if the scale has steadied; it is actively maintaining the lower weight, not just doing nothing. For a broader look at how tirzepatide fits into longer-term treatment, the Mounjaro treatment overview covers eligibility, the clinical programme and what private access involves. You can also read more on our weight loss treatment options page or speak to the team via our contact page if you have specific questions about your situation.